GRI
Price
$1.69
Change
-$0.33 (-16.34%)
Updated
Apr 2, 03:56 PM (EDT)
Capitalization
1.67M
IDYA
Price
$16.15
Change
+$1.38 (+9.34%)
Updated
Apr 2, 04:13 PM (EDT)
Capitalization
1.43B
41 days until earnings call
Ad is loading...

GRI vs IDYA

Header iconGRI vs IDYA Comparison
Open Charts GRI vs IDYABanner chart's image
GRI Bio
Price$1.69
Change-$0.33 (-16.34%)
Volume$1.2K
Capitalization1.67M
IDEAYA Biosciences
Price$16.15
Change+$1.38 (+9.34%)
Volume$1.72K
Capitalization1.43B
GRI vs IDYA Comparison Chart
Loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRI vs. IDYA commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRI is a Hold and IDYA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (GRI: $2.02 vs. IDYA: $14.77)
Brand notoriety: GRI and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRI: 4297% vs. IDYA: 277%
Market capitalization -- GRI: $1.67M vs. IDYA: $1.43B
GRI [@Biotechnology] is valued at $1.67M. IDYA’s [@Biotechnology] market capitalization is $1.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRI’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • GRI’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, GRI is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRI’s TA Score shows that 4 TA indicator(s) are bullish while IDYA’s TA Score has 4 bullish TA indicator(s).

  • GRI’s TA Score: 4 bullish, 4 bearish.
  • IDYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GRI and IDYA are a good buy in the short-term.

Price Growth

GRI (@Biotechnology) experienced а -69.85% price change this week, while IDYA (@Biotechnology) price change was -17.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.95%. For the same industry, the average monthly price growth was -7.12%, and the average quarterly price growth was -11.69%.

Reported Earning Dates

GRI is expected to report earnings on May 10, 2023.

IDYA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-4.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.43B) has a higher market cap than GRI($1.67M). IDYA YTD gains are higher at: -42.529 vs. GRI (-85.656). GRI has higher annual earnings (EBITDA): -7.87M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. GRI (4.75M). GRI has less debt than IDYA: GRI (131K) vs IDYA (19.2M). IDYA has higher revenues than GRI: IDYA (7M) vs GRI (0).
GRIIDYAGRI / IDYA
Capitalization1.67M1.43B0%
EBITDA-7.87M-323.14M2%
Gain YTD-85.656-42.529201%
P/E Ratio0.00N/A-
Revenue07M-
Total Cash4.75M676M1%
Total Debt131K19.2M1%
FUNDAMENTALS RATINGS
GRI vs IDYA: Fundamental Ratings
GRI
IDYA
OUTLOOK RATING
1..100
5053
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
10075
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
9892
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
70n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRI's Valuation (1) in the null industry is somewhat better than the same rating for IDYA (60). This means that GRI’s stock grew somewhat faster than IDYA’s over the last 12 months.

IDYA's Profit vs Risk Rating (75) in the null industry is in the same range as GRI (100). This means that IDYA’s stock grew similarly to GRI’s over the last 12 months.

IDYA's SMR Rating (95) in the null industry is in the same range as GRI (100). This means that IDYA’s stock grew similarly to GRI’s over the last 12 months.

IDYA's Price Growth Rating (92) in the null industry is in the same range as GRI (98). This means that IDYA’s stock grew similarly to GRI’s over the last 12 months.

GRI's P/E Growth Rating (95) in the null industry is in the same range as IDYA (100). This means that GRI’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRIIDYA
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
88%
Bullish Trend 21 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRVY62.191.69
+2.79%
GRAVITY Co Ltd
THCH2.990.06
+2.05%
TH International Ltd
TTC72.57-0.18
-0.25%
Toro Company (The)
FLNC4.80-0.05
-1.03%
Fluence Energy
SCPX0.13-0.01
-7.77%
SCORPIUS HOLDINGS INC.

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
-36.88%
IDYA - GRI
54%
Loosely correlated
-9.83%
INAB - GRI
39%
Loosely correlated
+4.04%
NLSP - GRI
38%
Loosely correlated
N/A
GOVX - GRI
37%
Loosely correlated
+1.89%
SNSE - GRI
35%
Loosely correlated
-12.44%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-9.83%
GRI - IDYA
54%
Loosely correlated
-36.88%
KRYS - IDYA
50%
Loosely correlated
-3.17%
IMNM - IDYA
49%
Loosely correlated
-6.98%
XENE - IDYA
49%
Loosely correlated
-8.67%
ETNB - IDYA
48%
Loosely correlated
-6.53%
More